Taken together, these data suggest that the RhoA-ROCK-signaling pathway may indirectly promote PLC-dependent reduction of Ki67+ nuclei in GBM #10 through alterations in the spatial location of PLC- and IP3-sensitive receptors. The gene discussed is HSPG2; the disease is glioblastoma.